Non-invasive Prediction of EArly Cardiac rEjection
for Heart Transplant
Sites in New York +21 more locations
Sponsor: Vanderbilt University Medical Center
Sex: All·Age: 6 - 25
Code: NCT07770659·Recruiting·Listed Aug 18, 2026
Clinical Trials at Columbia University
As of September 2026, 95 paid clinical trials are recruiting at Columbia University, located at 630 W 168TH ST, NEW YORK, NY 10032-3725, phone (212) 305-5084 in New York, New York. Active studies at this site cover conditions such as Breast Cancer, Prostate Cancer and Multiple Myeloma. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
Newly added in New York
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
96 clinical trials at Columbia University
·Clear filters· Get a weekly email when new trials open in New York, NY.
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
for Urinary Bladder Neoplasms
Sites in New York, The Bronx +39 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT05614739·Phase 1·Recruiting·Listed Nov 2022
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
for Acute Myeloid Leukemia (AML)
Sites in New York, Buffalo +40 more locations
Sponsor: Kura Oncology, Inc.
Sex: All·Age: 18+
Code: NCT07007312·Phase 3·Recruiting·Listed Jun 2025
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
for Parkinson Disease
Sites in New York, Manhasset +43 more locations
Sponsor: Neuron23 Inc.
Sex: All·Age: 40 - 80
Code: NCT06680830·Phase 2·Recruiting·Listed Nov 2024
Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature
for Peripheral Vascular Diseases
Sites in New York, Buffalo +36 more locations
Sponsor: Boston Scientific Corporation
Sex: All·Age: 18+
Code: NCT04674969·Recruiting·Listed Dec 2020
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
for Progressive Pulmonary Fibrosis
Sites in New York +26 more locations
Sponsor: Avalyn Pharma Inc.
Sex: All·Age: 18+
Code: NCT06951217·Phase 2·Recruiting·Listed Apr 2025
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
for Ovarian Cancer
Drug: Bevacizumab
Sites in New York +31 more locations
Sponsor: Daiichi Sankyo
Sex: Female·Age: 18+
Code: NCT06819007·Phase 3·Recruiting·Listed Feb 2025
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
for Parkinson Disease
Sites in New York +26 more locations
Sponsor: AskBio Inc
Sex: All·Age: 45 - 75
Code: NCT06285643·Phase 2·Recruiting·Listed Feb 2024
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
for Lymphoma, Non-Hodgkin's
Drug: LY4584180
Sites in New York, Rochester +19 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07226843·Phase 1·Recruiting·Listed Nov 2025
A Gaucher Disease Gene Therapy Trial With FLT201
for Gaucher Disease Type 1
Sites in New York +15 more locations
Sponsor: Spur Therapeutics
Sex: All·Age: 18+
Code: NCT07223944·Phase 3·Recruiting·Listed Nov 2025
Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma
for Glioblastoma
Sites in New York, Long Island City +9 more locations
Sponsor: Alpheus Medical, Inc.
Sex: All·Age: 18 - 80
Code: NCT07225621·Phase 2·Recruiting·Listed Nov 2025
A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis
for Clinical High Risk for Psychosis (CHR)
Sites in New York, Glen Oaks +13 more locations
Sponsor: Monument Therapeutics Limited
Sex: All·Age: 17 - 30
Code: NCT07226895·Phase 1, Phase 2·Recruiting·Listed Nov 2025
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
for Non-Small Cell Lung Cancer (NSCLC)
Drug: daraxonrasib
Sites in New York +19 more locations
Sponsor: Revolution Medicines, Inc.
Sex: All·Age: 18+
Code: NCT06128551·Phase 1, Phase 2·Recruiting·Listed Nov 2023
Investigations of Reproductive Cancers in Women
for Uterine Cancer
Sites in New York +12 more locations
Sponsor: PinkDx, Inc.
Sex: Female·Age: 45 - 100
Code: NCT06527157·Recruiting·Listed Jul 2024
A Study of GNTI-122 in Adults Recently Diagnosed With T1D
for Type 1 Diabetes (T1D)
Sites in New York +9 more locations
Sponsor: GentiBio, Inc
Sex: All·Age: 18 - 55
Code: NCT06919354·Phase 1·Recruiting·Listed Apr 2025
A Study of LY4175408 in Participants With Advanced Cancer
for Carcinoma, Non-Small-Cell Lung
Drug: LY4175408
Sites in New York +14 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07046923·Phase 1·Recruiting·Listed Jul 2025
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
for Gastric Adenocarcinoma
Sites in New York +9 more locations
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All·Age: 18+
Code: NCT05365581·Phase 1·Recruiting·Listed May 2022
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
for Non-small Cell Lung Cancer (NSCLC)
Sites in New York +20 more locations
Sponsor: Revolution Medicines, Inc.
Sex: All·Age: 18+
Code: NCT05379985·Phase 1, Phase 2·Recruiting·Listed May 2022
Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
for Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
Sites in New York +15 more locations
Sponsor: Electra Therapeutics Inc.
Sex: All·Age: 6+
Code: NCT05416307·Phase 2, Phase 3·Recruiting·Listed Jun 2022
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
for Pemphigus Vulgaris
Sites in New York +9 more locations
Sponsor: Cabaletta Bio
Sex: All·Age: 18+
Code: NCT04422912·Phase 1, Phase 2·Recruiting·Listed Jun 2020
A Phase 1/3 Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation
for AML
Sites in New York +20 more locations
Sponsor: TScan Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT05473910·Phase 1·Recruiting·Listed Jul 2022
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
for T-cell Lymphoma
Sites in New York +9 more locations
Sponsor: SciTech Development, Inc.
Sex: All·Age: 18+
Code: NCT04234048·Phase 1·Recruiting·Listed Jan 2020
A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV
for HIV -1 Infection
Drug: BNT351
Sites in New York +3 more locations
Sponsor: BioNTech SE
Sex: All·Age: 18 - 65·Accepts healthy volunteers
Code: NCT07392372·Phase 1·Recruiting·Listed Feb 2026
ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis
for X-linked Retinoschisis
Drug: ATSN-201
Sites in New York, Rochester +16 more locations
Sponsor: Atsena Therapeutics Inc.
Sex: All·Age: 6+
Code: NCT05878860·Phase 3·Recruiting·Listed May 2023
A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer
for Advanced or Metastatic Adrenocortical Carcinoma
Sites in New York +2 more locations
Sponsor: Daiichi Sankyo
Sex: All·Age: 18+
Code: NCT07189403·Phase 1·Recruiting·Listed Sep 2025
A Digitally Assisted Risk Reduction Platform for Youth at High Risk for Suicide
for Suicide
1 location in New York
Sponsor: Ksana Health
Sex: All·Age: 13 - 18
Code: NCT05920252·Recruiting·Listed Jun 2023
A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)
for Cystic Fibrosis
Sites in New York +3 more locations
Sponsor: Spirovant Sciences, Inc.
Sex: All·Age: 18 - 65
Code: NCT06526923·Phase 1, Phase 2·Recruiting·Listed Jul 2024
Serrantor OCT Study
for Critical Limb Ischemia
2 locations in New York
Sponsor: Cagent Vascular LLC
Sex: All·Age: 19+
Code: NCT06434194·Recruiting·Listed May 2024
Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs
for Myelofibrosis
Drug: Ruxolitinib
Sites in New York, The Bronx +2 more locations
Sponsor: Cellenkos, Inc.
Sex: All·Age: 18+
Code: NCT05423691·Phase 1·Recruiting·Listed Jun 2022
Multidimensional Sleep Health Intervention for Couples
for Blood Pressure
1 location in New York
Sponsor: Columbia University
Sex: All·Age: 30 - 65·Accepts healthy volunteers
Code: NCT07603245·Recruiting·Listed May 2026
Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)
for Optic Neuritis
Sites in New York +28 more locations
Sponsor: Mayo Clinic
Sex: All·Age: 18+
Code: NCT07100990·Phase 3·Recruiting·Listed Aug 2025
PREVENT ALL ALS Study
for Amyotrophic Lateral Sclerosis
Sites in New York +30 more locations
Sponsor: St. Joseph's Hospital and Medical Center, Phoenix
Sex: All·Age: 18+·Accepts healthy volunteers
Code: NCT06581861·Recruiting·Listed Sep 2024
DRP-104 in Patients With NFE2L2/KEAP1-altered Non-Small Cell Lung Cancer
for Non Small Cell Lung Cancer
2 locations in New York
Sponsor: NYU Langone Health
Sex: All·Age: 18+
Code: NCT07249372·Phase 2·Recruiting·Listed Nov 2025
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
for Frontotemporal Lobar Degeneration (FTLD)
Sites in New York +24 more locations
Sponsor: Mayo Clinic
Sex: All·Age: 18+·Accepts healthy volunteers
Code: NCT04363684·Recruiting·Listed Apr 2020
Long-Covid-19 Alleviation Through Learning Mindfulness Study
for Long COVID
1 location in New York
Sponsor: Columbia University
Sex: All·Age: 18+·Accepts healthy volunteers
Code: NCT07140094·Recruiting·Listed Aug 2025
Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs
for Cardiac Failure
Sites in New York +6 more locations
Sponsor: Northwestern University
Sex: All·Age: Up to 18
Code: NCT06532890·Recruiting·Listed Aug 2024
Functional Assessment in Liver Transplantation
for End Stage Liver Disease
Sites in New York +7 more locations
Sponsor: University of California, San Francisco
Sex: All·Age: 18+
Code: NCT03228290·Recruiting·Listed Jul 2017
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
for Type 1 Diabetes Mellitus
Sites in New York +8 more locations
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Sex: All·Age: 8 - 45
Code: NCT07142252·Phase 2·Recruiting·Listed Aug 2025
Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes
for Lung Transplant
Sites in New York +17 more locations
Sponsor: Duke University
Sex: All·Age: 18+
Code: NCT06399302·Recruiting·Listed May 2024
Improving Needs Among Older Adults
for Critical Illness
Sites in New York +3 more locations
Sponsor: Duke University
Sex: All·Age: 18+
Code: NCT06588556·Recruiting·Listed Sep 2024
Comprehensive HHT Outcomes Registry of the United States (CHORUS)
for Hereditary Hemorrhagic Telangiectasia
Sites in New York +15 more locations
Sponsor: Cure HHT
Sex: All·Age: All ages·Accepts healthy volunteers
Code: NCT06259292·Recruiting·Listed Feb 2024
Common conditions studied in New York
- Breast Cancer (92 active studies)
- Prostate Cancer (74 active studies)
- Multiple Myeloma (44 active studies)
- Colorectal Cancer (42 active studies)
- Ovarian Cancer (41 active studies)
- Endometrial Cancer (37 active studies)
Leading research sponsors in New York
- Memorial Sloan Kettering Cancer Center
- NYU Langone Health
- Columbia University
- Icahn School of Medicine at Mount Sinai
- Weill Medical College of Cornell University
Frequently asked questions
How many paid clinical trials are currently recruiting in New York?
There are approximately 3,375 recruiting clinical trials in New York, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in New York pay participants?
Most recruiting trials in New York compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in New York?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in New York?
The most common conditions under active study in New York include Breast Cancer (92), Prostate Cancer (74), Multiple Myeloma (44), Colorectal Cancer (42), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in New York?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in New York on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in New York?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in New York?
Recruiting research sites in New York include Memorial Sloan Kettering Cancer Center, NYU Langone Health, Icahn School of Medicine at Mount Sinai, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in New York right now?
The largest active categories in New York are Cancer & tumors (1,129), Neurology & pain (198), Cardiovascular (195). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Columbia University?
Columbia University is located at 630 W 168TH ST, NEW YORK, NY 10032-3725. Use the Google Maps link in the intro above to get directions.
How do I contact Columbia University?
You can reach Columbia University by phone at (212) 305-5084. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.
Browse more clinical trials
Other cities in New York
The Bronx, NY(553)Rochester, NY(474)Buffalo, NY(415)Commack, NY(321)Harrison, NY(301)Uniondale, NY(226)Brooklyn, NY(205)Syracuse, NY(179)Stony Brook, NY(171)Albany, NY(164)Lake Success, NY(146)New Hyde Park, NY(120)Mineola, NY(116)Manhasset, NY(100)Valhalla, NY(97)Rockville Centre, NY(83)Staten Island, NY(77)East Syracuse, NY(57)Mount Kisco, NY(44)White Plains, NY(42)Amherst, NY(37)Bay Shore, NY(32)Flushing, NY(32)Westbury, NY(32)Great Neck, NY(31)Roslyn, NY(31)Webster, NY(29)Poughkeepsie, NY(26)Shirley, NY(26)Queens, NY(25)Long Island City, NY(24)Sleepy Hollow, NY(24)Ithaca, NY(22)Williamsville, NY(22)Glens Falls, NY(19)Garden City, NY(17)New Windsor, NY(17)West Islip, NY(17)Camillus, NY(16)Jamaica, NY(16)Cedarhurst, NY(15)Greenlawn, NY(15)Cooperstown, NY(14)Liverpool, NY(14)Manhattan, NY(14)Binghamton, NY(13)Hawthorne, NY(13)Laurelton, NY(13)Oswego, NY(13)Verona, NY(13)Clifton Park, NY(12)Port Jefferson Station, NY(12)Glen Oaks, NY(11)Rego Park, NY(11)East Hills, NY(10)Syosset, NY(10)East White Plains, NY(9)Huntington, NY(9)Oceanside, NY(9)Old Westbury, NY(9)